10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164,400,637 | -28.5% | 3,985,470 | -3.3% | 0.56% | -21.6% |
| Q2 2023 | $230,075,821 | +10.3% | 4,120,269 | +10.2% | 0.71% | +3.9% |
| Q1 2023 | $208,530,077 | +178352.0% | 3,737,768 | +16.6% | 0.69% | +55.8% |
| Q4 2022 | $116,855 | -99.9% | 3,206,783 | -5.4% | 0.44% | +21.8% |
| Q3 2022 | $96,581,000 | -39.5% | 3,391,177 | -3.8% | 0.36% | -34.4% |
| Q2 2022 | $159,591,000 | -34.5% | 3,526,878 | +10.2% | 0.55% | -1.4% |
| Q1 2022 | $243,530,000 | -1.7% | 3,201,394 | +92.4% | 0.56% | +21.7% |
| Q4 2021 | $247,865,000 | – | 1,663,967 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |